Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Kuwait KWF

National International Holding Company K.S.C.P. (NIH.KW)

Compare
167.00
+1.00
+(0.60%)
As of 12:04:00 PM GMT+3. Market Open.
Loading Chart for NIH.KW
  • Previous Close 166.00
  • Open 165.00
  • Bid 167.00 x --
  • Ask 168.00 x --
  • Day's Range 164.00 - 169.00
  • 52 Week Range 87.00 - 498.00
  • Volume 1,154,630
  • Avg. Volume 4,141,438
  • Market Cap (intraday) 38.7M
  • Beta (5Y Monthly) 0.18
  • PE Ratio (TTM) 16.70
  • EPS (TTM) 0.01
  • Earnings Date --
  • Forward Dividend & Yield 0.01 (3.61%)
  • Ex-Dividend Date Jul 9, 2024
  • 1y Target Est --

National International Holding Company K.S.C.P., together with its subsidiaries, engages in the financial and real estate investing, and industrial activities. The company's Financial Investing segment participates in financial and real estate funds. Its Real Estate Investing segment invests in, trades in, constructs or develops, and sells real estate properties and other related real estate services. The company's Industrial segment engages in manufacturing and selling chemical products. The company also owns intellectual property rights, including patents, trademarks or industrial forms, franchise rights, and other rights. The company was incorporated in 1979 and is based in Kuwait City, Kuwait.

nih-kw.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NIH.KW

View More

Performance Overview: NIH.KW

Trailing total returns as of 3/12/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD .

YTD Return

NIH.KW
49.85%
MSCI WORLD
2.45%

1-Year Return

NIH.KW
54.64%
MSCI WORLD
7.74%

3-Year Return

NIH.KW
19.83%
MSCI WORLD
27.74%

5-Year Return

NIH.KW
146.88%
MSCI WORLD
83.96%

Compare To: NIH.KW

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NIH.KW

View More

Valuation Measures

Annual
As of 3/11/2025
  • Market Cap

    38.47M

  • Enterprise Value

    23.36M

  • Trailing P/E

    16.43

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.11

  • Price/Book (mrq)

    0.97

  • Enterprise Value/Revenue

    4.46

  • Enterprise Value/EBITDA

    8.38

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    29.80%

  • Return on Assets (ttm)

    3.00%

  • Return on Equity (ttm)

    5.02%

  • Revenue (ttm)

    7.42M

  • Net Income Avi to Common (ttm)

    2.21M

  • Diluted EPS (ttm)

    0.01

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.41M

  • Total Debt/Equity (mrq)

    5.59%

  • Levered Free Cash Flow (ttm)

    -508.94k

Research Analysis: NIH.KW

View More

Company Insights: NIH.KW

Research Reports: NIH.KW

View More

People Also Watch